Indication & Dosage :
Arixtra (Fondaparinux Sodium) is a prescription medicine used to treat serious blood clots in the legs and/or lungs. Fondaparinux Sodium is usually used Prophylaxis of deep vein thrombosis (DVT) or acute pulmonary embolism (PE) when administered in conjunction with warfarin. If untreated, blood clots can travel to the lungs, heart, or brain, causing serious (possibly fatal) breathing problems, heart attack, or stroke. Fondaparinux Sodium is also used to prevent blood clots after certain surgeries with an increased risk of blood clots (such as hip fracture, abdominal, knee/hip replacement). Fondaparinux Sodium is a drug similar to heparin that works by blocking certain natural substances in the blood that cause clotting. Arixtra is manufactured by ASPEN Pharma Ltd. in FRANCE.
Fondaparinux Sodium is given by injection into a vein by a health care professional. Patient`s doctor will choose what portion is important and how frequently patient need to take it. Dosage is based on Patient`s medical condition, body size, and response to treatment.
Side Effects :
The most common adverse reactions of Fondaparinux Sodium are:
Pain, bruising, redness, and swelling at the injection site.
The above information comes from the Internet. Please consult with doctor for medical advice.
Suggestion :
* Any advice on the use of the drug is for reference only. Please consult with doctor for medical advice. All Names, logos, trademarks are property of their respective owners. Watermarks, QR code used for identification purposes only.
